Cardiac Membrane Biology Laboratory

The Cardiac Membrane Biology Laboratory aims to improve the lives of people suffering cardiac related health issues.

Our research focuses on one of the body’s most crucial molecules – a molecule which is vital for the contraction of heart cells and therefore the pumping of the heart. As we develop a better understanding of this molecule through laboratory-based experiments, we explore treatments for heart failure, irregular heartbeat and heart damage following cancer treatment.

Our laboratory-based research has led to the discovery of a new potential treatment for heart failure. We are about to begin a clinical trial of this approach with our collaborators based in Denmark.


Lead

Helge HeadshotProf Helge Rasmussen.

Chair of Cardiology
Medicine, Northern Clinical School

Elisha-Hamilton Dr Elisha Hamilton, PhD

Laboratory Manager
Medicine, Northern Clinical School

PREVENTION OF CARDIAC SIDE EFFECTS OF CANCER TREATMENT

This project will investigate a new drug combination therapy that has potential benefits in cancer treatment induced heart failure by targeting the sodium/potassium pump function.

A NEW DRUG COMBINATION THERAPY FOR HEART FAILURE

This project will investigate a drug combination therapy that has potential benefits in heart failure treatment by targeting the sodium/potassium pump function.

Events, News and Seminars

Common medication may lower risk of “heartbreak”

Common medication may lower risk of “heartbreak”

RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common med..... Read more

Category: Research Excellence

Research spotlight on specialist NICU team

Research spotlight on specialist NICU team

Celebrity couple Hayden James and Jennifer Luby shared their emotional journey following the premat..... Read more

Category: Research Excellence

Newsletter

Newsletter

Read more

Category: Newsletters